EUVIMED · CrossrefJournal
Journal of Neural Transmission
ISSN 0300-9564 · Springer Science and Business Media LLC
Latest articles
The effect of levodopa on non-motor symptoms in Parkinson’s disease: the good, the bad and the ugly
AlcoRhythm vs. algorithm: Is a stepped approach to Parkinson’s therapy still sensible?
How to determine the suitability of Parkinson’s disease patients for device-aided therapies: a practical approach
The CheckBRAIN™ platform: architecture for post-screening brain health care across the Parkinson’s disease continuum
Clinical correlates of cognitive impairment in progressive supranuclear palsy and multiple system atrophy: a comparative neuropsychological study
Neutrophil-to-lymphocyte ratio predicts infusion-site skin nodules in Parkinson’s disease patients receiving foslevodopa/foscarbidopa subcutaneous infusion
Peripheral α-Synuclein oligomer accumulation in MAPT p.D750V–associated autosomal-dominant parkinsonism: evidence from in vivo skin biopsies
Subcutaneous apomorphine and the nonmotor features of Parkinson’s disease
Age-dependent subcortical iron accumulation in chronic schizophrenia: findings from a quantitative susceptibility mapping study
The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation—a position paper
Dysphagia and gastrointestinal disorders in Parkinson’s disease: towards a diagnostic standard operating procedure for the interprofessional neurological outpatient care team
Why dopamine replacement therapy will stay as a cornerstone in the treatment of Parkinson disease: a personal opinion
The German Parkinson expert meetings
Sublingual apomorphine for Parkinsonian tremor: a post-hoc analysis of pivotal trial data
Population pharmacokinetic analyses comparing immediate-release levodopa/carbidopa, controlled-release levodopa/carbidopa, and IPX203. Findings from a phase 1 study in healthy volunteers
Multiple system atrophy: cure and care
Toward the prevention of clinically manifest Parkinson’s disease
Quality management and specifications of multidisciplinary Parkinson’s disease management: an expert opinion
Not always the usual suspect: symptom variations in Parkinson’s disease beyond ON-OFF fluctuations
German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson’s disease
On-demand therapies–emergency medication or daily routine?
Early clinical experience with IPX203 in Parkinson’s disease with motor fluctuations
Twenty-five years of progress in Parkinson’s disease research: from dopamine replacement to biological definition and regenerative therapy
Improving the clinical trial landscape for Parkinson syndromes in Germany
Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats
Cross-sectional and longitudinal validation of short and long versions of the progressive supranuclear palsy quality of life scale
HDL cholesterol indicates neurodegenerative vulnerability in dementia with lewy bodies
Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson’s disease patients: the role of clinical and demographic factors
Remote smartphone-based spoken language screening predicts clinical markers in Huntington’s disease
Prevalence and state-dependent patterns of non-motor fluctuations in Parkinson’s disease
Volumes
2026 · 2402025 · 1952024 · 1352023 · 1342022 · 1372021 · 1602020 · 1602019 · 1542018 · 1632017 · 1682016 · 1602015 · 1992014 · 1642013 · 2122012 · 1752011 · 1912010 · 1672009 · 1952008 · 1992007 · 2172006 · 1862005 · 1462004 · 1202003 · 1162002 · 1302001 · 1242000 · 1241999 · 1001998 · 1041997 · 1301996 · 1381995 · 931994 · 961993 · 931992 · 991991 · 1031990 · 961989 · 1001988 · 961987 · 87
EUVIMED